President Trump makes an announcement on healthcare affordability — 8/31/2026
Speakers
Donald Trump
— President of the United States
Robert F. Kennedy Jr.
— Secretary of Health and Human Services
Howard Lutnick
— Secretary of Commerce
Summary
President Trump hosts a healthcare affordability event announcing nine new pharmaceutical companies joining his most favored nation drug pricing initiative. The administration says 26 companies representing 90% of the U.S. pharmaceutical market have agreed to steep discounts, projected at $600 billion in savings, alongside $638 billion in reshoring investment. The Q&A also covers Iran, Venezuela oil supplies, oil prices, Fed policy, and the midterms.
- Trump announces nine new drug-pricing deals with pharmaceutical companies.
- Total agreements now cover 26 companies and about 90% of the U.S. drug market.
- The administration projects $600 billion in drug savings and 50 to 80 percent price cuts.
- Companies commit to Medicaid pricing and future medicines at lowest world prices.
- Pharma reshoring investments total $638 billion, including $19.6 billion from the event group.
- Trump says oil prices have remained contained due to the Strait of Hormuz and will ultimately fall.
- Q&A includes Iran strikes, Venezuela oil deals, Fed rates, and midterm politics.
Ideas
Oil prices should fall on supply.
Trump says the Strait of Hormuz remains open with about 30 ships moving per night and plenty of oil flowing, so oil prices have not spiked as feared; he also says the Venezuela oil deal will ultimately bring prices down.
Pharma stocks rise on voluntary pricing deals.
Trump argues the voluntary most favored nation drug pricing agreements are not rent regulation, and he says pharmaceutical stocks have gone up, not down, because the deal is seen as free enterprise rather than government price controls.
Exxon, Chevron gain from Venezuela deal.
Trump highlights Exxon and Chevron entering Venezuela and bidding alongside other U.S. oil companies, calling it possibly the greatest deal ever; heavy Venezuelan oil is expected to flow to U.S. refineries and generate substantial value.
